Vaccine for HER2 breast cancer shows early promise
A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer.
Mar 12, 2019
0
752
A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer.
Mar 12, 2019
0
752
A preclinical study has found multiple myeloma is highly sensitive to a newly developed experimental therapy, according to research published today by Peter Mac scientists.
May 21, 2021
0
41
Obesity is now a global epidemic, and it is increasing people's risk for cancer. The National Cancer Institute lists more than a dozen cancers that are associated with overweight and obesity. But how obesity increases cancer ...
Dec 13, 2022
0
189
Cancers are often heavily reliant on breaking down fats for their growth and spread, and could be treated by a highly innovative combination of new drugs and dietary changes, a major new study concludes.
Jun 19, 2020
0
300
Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375,000 patients will die from ...
Jun 8, 2023
0
248
Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer.
Mar 2, 2018
0
271
A study of 11,945 people in six European countries has shown that people with type 2 diabetes who develop cancer are more likely to be diagnosed with advanced disease if the condition is one that is not screened for routinely.
Nov 16, 2022
0
30
Scientists have revealed that a key molecule in breast and lung cancer cells can help switch off the cancers' ability to spread around the body.
Mar 21, 2016
0
2213
Scientists at Sinai Health and the University of Toronto say a new drug designed to block an enzyme essential for the survival of certain cancer cells shows promise in curbing tumor growth.
Apr 29, 2022
0
40
The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers. Knowing more about the activation process has led researchers to be able to induce greater vulnerability by cancer cells ...
May 20, 2016
0
495